Industry

Life Sciences and Health Care

Navigating complexities in the life sciences and health care industries is no easy task. Successfully competing in the space requires a partner with a holistic, collaborative approach and a global perspective. It calls for a strategy informed by asking the right questions and rooted in identifying creative solutions to...

Boston Compliance Forum

Join the Hogan Lovells Boston team along with regional and international colleagues for an informative breakfast forum in Cambridge, MA. The forum features two sessions that explore a range ...

Quick view Full view

Blog Post

FDA issues benefit-risk framework for assessing opioid drug applications, announces public meeting

Agency seeks input on “comparative advantage” requirement for new opioids

Quick view Full view

Blog Post

The European Commission releases an updated Borderline Manual for medical devices

The European Commission has updated the Manual on borderline and classification in the community regulatory framework for medical devices (Borderline Manual). The Borderline Manual is...

Quick view Full view

Hogan Lovells Publications

View from the Horizon: Artificial Intelligence and Cannabusiness in London

On May 16 the second edition of our new global series, Life Sciences and Health Care Horizons, took place in London featuring two panel discussions that focused on the challenges and...

Quick view Full view

Published Works

Benchmark pricing Polity

In recent weeks, several leading pharmaceutical companies have been accused of conspiring to inflate the pricing of their products, some of which are used in the treatment of illnesses such ...

Quick view Full view

Awards and Rankings

Hogan Lovells continues growth and recognition in 2019 Legal 500 U.S. rankings

Washington D.C., 6 June 2019 – Hogan Lovells is pleased to announce that the firm has again improved its performance in the U.S. Legal 500 Rankings, achieving “Top Tier”...

Quick view Full view
Loading data